ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

NCI sponsors Year-Round Shannon Awards Program

April 4, 1996

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000

Cancer Centers Begin Free Genetic Tumor Testing Project For Lung Cancer Patients

October 30, 2009

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012